Phase II study on ET-743 [ecteinascidin 743; trabectedin] in advanced soft tissue sarcomas of the adult.
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2012
At a glance
- Drugs Trabectedin (Primary)
- Indications Brain cancer; Ovarian cancer; Sarcoma; Uterine cancer
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.